Build Discounted Cash Flow (DCF) valuation models. Calculate intrinsic value with customizable assumptions. Generate professional valuation reports.
npx skills add https://github.com/claude-office-skills/skills --skill dcf-valuation
I help you build Discounted Cash Flow (DCF) models to estimate the intrinsic value of companies. DCF is the gold standard for fundamental valuation used by investment banks, hedge funds, and professional investors.
What I can do:
What I cannot do:
I need:
Key assumptions to specify (or I'll use industry defaults):
Unlevered Free Cash Flow (UFCF) =
EBIT × (1 - Tax Rate)
+ Depreciation & Amortization
- Capital Expenditures
- Change in Net Working Capital
WACC = (E/V × Re) + (D/V × Rd × (1 - Tc))
Where:
E = Market value of equity
D = Market value of debt
V = E + D (total value)
Re = Cost of equity (CAPM: Rf + β × Market Risk Premium)
Rd = Cost of debt
Tc = Corporate tax rate
Re = Rf + β × (Rm - Rf)
Where:
Rf = Risk-free rate (10-year Treasury)
β = Stock beta (systematic risk)
Rm - Rf = Equity risk premium (typically 5-6%)
Terminal Value = FCF(n+1) / (WACC - g)
Where:
FCF(n+1) = Final year FCF × (1 + g)
g = Terminal growth rate (typically 2-3%, ≤ GDP growth)
Terminal Value = EBITDA(n) × Exit Multiple
Common multiples by sector:
- Technology: 10-15x
- Healthcare: 8-12x
- Consumer: 6-10x
- Industrial: 5-8x
Enterprise Value = Σ [FCF(t) / (1 + WACC)^t] + [TV / (1 + WACC)^n]
Equity Value = Enterprise Value - Net Debt + Cash
Intrinsic Value per Share = Equity Value / Shares Outstanding
# DCF Valuation Model: [Company Name]
**Valuation Date**: [Date]
**Analyst**: AI-Generated
**Model Type**: [Standard/Two-Stage/Three-Stage]
---
## Executive Summary
| Metric | Value |
|--------|-------|
| **Intrinsic Value per Share** | $XX.XX |
| **Current Market Price** | $XX.XX |
| **Upside/Downside** | +/-XX% |
| **Implied Recommendation** | [Undervalued/Fair/Overvalued] |
---
## Key Assumptions
### Revenue Projections
| Year | Revenue ($M) | Growth % |
|------|-------------|----------|
| Base (Current) | X,XXX | - |
| Year 1 | X,XXX | XX% |
| Year 2 | X,XXX | XX% |
| Year 3 | X,XXX | XX% |
| Year 4 | X,XXX | XX% |
| Year 5 | X,XXX | XX% |
### Margin Assumptions
| Metric | Year 1 | Year 5 | Rationale |
|--------|--------|--------|-----------|
| EBITDA Margin | XX% | XX% | [Reason] |
| Capex/Revenue | XX% | XX% | [Reason] |
| D&A/Revenue | XX% | XX% | [Reason] |
### WACC Calculation
| Component | Value | Source/Assumption |
|-----------|-------|-------------------|
| Risk-free Rate | X.X% | 10-Year Treasury |
| Beta | X.XX | Bloomberg/Calculated |
| Equity Risk Premium | X.X% | Historical average |
| Cost of Equity | XX.X% | CAPM |
| Cost of Debt | X.X% | Credit spread |
| Tax Rate | XX% | Effective rate |
| Debt/Total Capital | XX% | Current structure |
| **WACC** | **X.X%** | |
### Terminal Value
| Method | Value ($M) | As % of EV |
|--------|-----------|------------|
| Gordon Growth (g=X%) | X,XXX | XX% |
| Exit Multiple (Xx EBITDA) | X,XXX | XX% |
| **Selected** | **X,XXX** | **XX%** |
---
## Free Cash Flow Projections
| ($M) | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Terminal |
|------|--------|--------|--------|--------|--------|----------|
| Revenue | | | | | | |
| EBITDA | | | | | | |
| (-) D&A | | | | | | |
| EBIT | | | | | | |
| (-) Taxes | | | | | | |
| NOPAT | | | | | | |
| (+) D&A | | | | | | |
| (-) Capex | | | | | | |
| (-) ΔNWC | | | | | | |
| **UFCF** | | | | | | |
---
## Valuation Summary
| Component | Value ($M) |
|-----------|-----------|
| PV of Projected FCFs | X,XXX |
| PV of Terminal Value | X,XXX |
| **Enterprise Value** | **X,XXX** |
| (-) Net Debt | (X,XXX) |
| (+) Cash | X,XXX |
| **Equity Value** | **X,XXX** |
| Shares Outstanding | XXX M |
| **Value per Share** | **$XX.XX** |
---
## Sensitivity Analysis
### WACC vs Terminal Growth Rate
| WACC ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% |
|--------------|------|------|------|------|
| 8.0% | $XX | $XX | $XX | $XX |
| 8.5% | $XX | $XX | $XX | $XX |
| 9.0% | $XX | $XX | **$XX** | $XX |
| 9.5% | $XX | $XX | $XX | $XX |
| 10.0% | $XX | $XX | $XX | $XX |
### Key Drivers Impact
| Assumption Change | Impact on Value |
|-------------------|-----------------|
| WACC +1% | -XX% |
| Terminal Growth +0.5% | +XX% |
| Revenue CAGR +2% | +XX% |
| EBITDA Margin +2% | +XX% |
---
## Risks to Valuation
1. **Model Risk**: DCF highly sensitive to WACC and terminal growth assumptions
2. **Execution Risk**: Projected growth may not materialize
3. **Market Risk**: Multiple compression in downturn
4. **[Company-Specific Risk]**: [Detail]
---
## Disclaimer
This valuation model is for educational and informational purposes only. It does not constitute investment advice. The intrinsic value estimate is based on assumptions that may not reflect reality.
Build a DCF model for a SaaS company with:
- Current revenue: $500M
- Revenue growth: 25% declining to 15% over 5 years
- EBITDA margin: 20% improving to 30%
- Current stock price: $45
- Shares outstanding: 100M
[Complete DCF model with all calculations...]
*Built by the Claude Office Skills community. Contributions welcome!*
Integration with protocols.io API for managing scientific protocols. This skill should be used when working with protocols.io to search, create, update, or publish protocols; manage protocol steps and materials; handle discussions and comments; organize workspaces; upload and manage files; or integrate protocols.io functionality into workflows. Applicable for protocol discovery, collaborative protocol development, experiment tracking, lab protocol management, and scientific documentation.
Analyzes job descriptions and generates tailored resumes that highlight relevant experience, skills, and achievements to maximize interview chances
Generate Excalidraw diagrams from natural language descriptions. Use when asked to "create a diagram", "make a flowchart", "visualize a process", "draw a system architecture", "create a mind map", or "generate an Excalidraw file". Supports flowcharts, relationship diagrams, mind maps, and system architecture diagrams. Outputs .excalidraw JSON files that can be opened directly in Excalidraw.
Build and distribute Expo development clients locally or via TestFlight
Use when you have a written implementation plan to execute in a separate session with review checkpoints
Data structure for annotated matrices in single-cell analysis. Use when working with .h5ad files or integrating with the scverse ecosystem. This is the data format skill—for analysis workflows use scanpy; for probabilistic models use scvi-tools; for population-scale queries use cellxgene-census.
Benchling R&D platform integration. Access registry (DNA, proteins), inventory, ELN entries, workflows via API, build Benchling Apps, query Data Warehouse, for lab data management automation.
Comprehensive molecular biology toolkit. Use for sequence manipulation, file parsing (FASTA/GenBank/PDB), phylogenetics, and programmatic NCBI/PubMed access (Bio.Entrez). Best for batch processing, custom bioinformatics pipelines, BLAST automation. For quick lookups use gget; for multi-service integration use bioservices.
Take claude-office-skills/dcf-valuation from the repository into ~/.claude/skills for personal
use, or into .claude/skills inside a project.
The agent identifies a skill by the name field in its header. Two skills with the
same name cannot sit side by side — one of them will be ignored.